Weak Association Observed Between Systemic Vasculitis and Myocardial Infarction
Patients with vasculitis aged older than 40 years who had been admitted to teaching hospitals were included in the study.
Diagnosis & Disease Information
Telmisartan Does Not Improve 6-Minute Walk Distance in PAD
Six-minute walk distance not improved with telmisartan versus placebo in patients with lower-extremity peripheral arterial disease
Daily Timing of Antihypertensives Does Not Impact Effectiveness
Evening dosing of blood pressure medication no better than morning dosing
Polypill Cuts Cardiovascular Event Risk in Seniors With Recent MI
Polypill comprising aspirin, ramipril, atorvastatin effective for secondary prevention of cardiovascular disease in older adults
Adenoviral-Based COVID-19 Vaccines May Up Short-Term CV Risk
Increased incidence of myocardial infarction, pulmonary embolism seen in second week after first dose of Oxford-AstraZeneca vaccine
Racial, Ethnic Disparities Seen in Management of NSTEMI
Blacks, Hispanics less likely than Whites to undergo coronary angiography, PCI for acute non-ST-segment elevation myocardial infarction
Stopping RAS Inhibitors After AKI Ups Risk for Adverse Events
Findings may aid physicians in their clinical decision-making in the absence of randomized clinical trial data, according to investigators.
Hypertension Ups Odds of Omicron-Variant COVID-19 Hospitalization
Observational study findings highlight a “persistent and marked” association between hypertension and risk for severe COVID-19, even among fully vaccinated patients, according to investigators.
Aspirin May Lower Cardiovascular Risks in Chronic Kidney Disease Population
Aspirin use among patients with chronic kidney disease was associated with reduced risk for major adverse cardiovascular events.
USPSTF Issues Recommendations on Aspirin Use to Prevent Cardiovascular Disease
These recommendations only apply to individuals who do not have a history of CVD and are not already taking daily aspirin.
